@article{138cfb50bce24d688962b9cdf32b0c4e,
title = "UPDATE – 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis:Endorsement of the 2021 Cancer Care Ontario guidelines on prostate multiparametric magnetic resonance imaging – Summary of changes",
author = "Mason, {Ross J.} and Karim Marzouk and Antonio Finelli and Fred Saad and So, {Alan I.} and Violette, {Phillipe D.} and Breau, {Rodney H.} and Rendon, {Ricardo A.}",
note = "Funding Information: Competing interests: Dr. Mason has participated in advisory boards and has been a speaker for Abbvie, Sanofi, TerSera, and Verity. Dr. Saad has received honoraria from Astellas, AstraZeneca, Bayer, Janssen, Knight, Myovant, Novartis, Sanofi, and Pfizer. Dr. So has participated in advisory boards for Abbvie, Amgen, Bayer, Ferring, Janssen, Merck, and TerSera. Dr. Rendon has participated in advisory boards for Abbvie, Amgen, Astellas, AstraZeneca, Bayer, Ferring, Janssen, Pfizer, Roche, Sanofi, and Tolmar; has been a speaker for Abbvie, Amgen, Astellas, AstraZeneca, Bayer, Ferring, Janssen, Pfizer, Roche, and Sanofi; has received grants and/or honoraria from Abbvie, Astellas, Bayer, Ferring, Janssen, Sanofi, Tolmar, and TerSera; holds investments in Myovant; and has participated in clinical trials supported by Abbvie, Astellas, Bavarian Nordic, Bayer, Ferring, Janssen, Myovant, and Sanofi. The remaining authors do not report any competing personal or financial interests related to this work.",
year = "2022",
doi = "10.5489/CUAJ.7832",
language = "English",
volume = "16",
pages = "86--87",
journal = "Yosetsu Gakkai Shi/Journal of the Japan Welding Society",
issn = "0021-4787",
publisher = "Japan Welding Society",
number = "4",
}
